Status:
ENROLLING_BY_INVITATION
Genetic Investigations in Spontaneous Coronary Artery Dissection (SCAD)
Lead Sponsor:
Mayo Clinic
Conditions:
Spontaneous Coronary Artery Dissection
SCAD
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the research is to identify mutations (defects in the genetic blueprint) that cause spontaneous coronary artery dissection (SCAD), in other words, spontaneous tears in blood vessels tha...
Detailed Description
Study question: Do mutations within certain genes cause or confer susceptibility to spontaneous coronary artery dissection (SCAD)? Specific aims: 1. Create a genomic DNA and plasma biobank for indiv...
Eligibility Criteria
Inclusion
- Men and women able to give informed consent and complete a 2 page questionnaire
- Diagnosis of one or more episodes of spontaneous coronary artery dissection (SCAD)
- Biological parent of individual with SCAD
- Relative with fibromuscular dysplasia, arterial aneurysm, or arterial dissection
Exclusion
- Lack of confirmation of SCAD diagnosis
Key Trial Info
Start Date :
May 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT01427179
Start Date
May 1 2011
End Date
December 1 2030
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905